We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

295 hedge funds and large institutions have $720M invested in Intellia Therapeutics in 2025 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 95 increasing their positions, 96 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more call options, than puts

Call options by funds: $7.04M | Put options by funds: $6.43M

9% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 46

0.36% more ownership

Funds ownership: 97.48% → 97.84% (+0.36%)

0% more funds holding

Funds holding: 294 → 295 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 96

38% less capital invested

Capital invested by funds: $1.16B → $720M (-$438M)

Holders
295
Holders Change
+1
Holders Change %
+0.34%
% of All Funds
3.95%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
50
Increased
95
Reduced
96
Closed
46
Calls
$7.04M
Puts
$6.43M
Net Calls
+$607K
Net Calls Change
-$4.36M

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$38.2M
2
CGH
Contrarius Group Holdings
Bermuda
+$10.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.68M
4
AIM
ARK Investment Management
Florida
+$4.79M
5
Stifel Financial
Stifel Financial
Missouri
+$3.96M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.16M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$7.99M
3
State Street
State Street
Massachusetts
-$7.02M
4
UBS Group
UBS Group
Switzerland
-$6.21M
5
VPC
Vestal Point Capital
New York
-$6.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCS
26
Himension Capital (Singapore)
Singapore
$5.35M -$2.35M -233,039 -24%
BBA
27
Baker Bros. Advisors
New York
$4.58M – – –
TI
28
Trexquant Investment
Connecticut
$4.3M -$636K -62,936 -9%
Millennium Management
29
Millennium Management
New York
$4.17M -$833K -82,437 -12%
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
$4.02M +$532K +52,700 +10%
DVF
31
Discovery Value Fund
Singapore
$3.99M – – –
JP Morgan Chase
32
JP Morgan Chase
New York
$3.87M -$150K -14,893 -3%
UBS AM
33
UBS AM
Illinois
$3.71M +$389K +38,521 +8%
JF
34
Jump Financial
Illinois
$3.58M +$1.43M +141,172 +39%
GIM
35
Granahan Investment Management
Massachusetts
$3.38M +$1.71M +169,436 +55%
American Century Companies
36
American Century Companies
Missouri
$3.35M +$180K +17,855 +4%
PP
37
PDT Partners
New York
$3.27M +$1.34M +132,638 +40%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$3.05M -$995K -98,515 -19%
SFM
39
Sphera Funds Management
Israel
$2.71M -$859K -85,000 -18%
AC
40
Armistice Capital
New York
$2.59M +$3.68M +364,000 New
Wells Fargo
41
Wells Fargo
California
$2.54M +$807K +79,866 +29%
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$2.42M -$990K -98,001 -22%
VAS
43
Vestmark Advisory Solutions
Massachusetts
$2.22M -$640K -63,409 -17%
Citigroup
44
Citigroup
New York
$2.11M +$207K +20,476 +7%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$2M -$27K -2,671 -0.9%
N
46
Nuveen
North Carolina
$1.94M +$117K +11,600 +4%
Verition Fund Management
47
Verition Fund Management
Connecticut
$1.93M +$2.63M +260,253 +2,328%
Deutsche Bank
48
Deutsche Bank
Germany
$1.79M -$9.48K -939 -0.4%
Raymond James Financial
49
Raymond James Financial
Florida
$1.77M -$1.63M -161,842 -39%
Barclays
50
Barclays
United Kingdom
$1.71M -$723K -71,536 -23%
1
2
3 4 5

NTLA Hedge Fund Activity: Q1 2025 in Review

295 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q1 2025, worth a combined $720M — down 38% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new NTLA positions and 46 closed out — a net gain of 4 holders — while 95 added to existing stakes and 96 trimmed.

The largest buyer was Capital International Investors, opening a new position worth an estimated $38.2M. The largest seller was Wellington Management Group, exiting entirely with an estimated $8.16M sold.

  • 295 institutional investors held Intellia Therapeutics (NTLA) as of Q1 2025, up from 294 in Q4 2024.
  • Funds reported $720M of Intellia Therapeutics stock for Q1 2025, down 38% quarter-over-quarter.
  • 50 funds opened new Intellia Therapeutics positions in Q1 2025 and 46 closed out, a net change of +4 holders.
  • The largest Intellia Therapeutics buyer in Q1 2025 was Capital International Investors, an estimated $38.2M added.
  • The largest Intellia Therapeutics seller in Q1 2025 was Wellington Management Group, an estimated $8.16M sold.

Based on aggregated 13F filings for Q1 2025.